UNSPSC 51112604: Fotemustine

This classification denotes a nitrosourea compound with the molecular formula C9H19ClN3O5P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GQ7JL9P5I2, chemically known as phosphonic acid, (1-((((2-chloroethyl)nitrosoamino)carbonyl)amino)ethyl)-, diethyl ester but more generally known as fotemustine, which bears US NIH Compound Identifier 104799. European Medicines Agency schedules Fotemustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07809MIG.

UNSPSC 51112604 Fotemustine is a Commodity code covering a specific chemotherapy agent used in cancer treatment protocols. State and local procurement activity under this code reflects pharmaceutical supply requisitions by health and human services agencies managing prescription benefit programs, particularly those seeking to optimize acquisition channels and reduce costs through direct-manufacturer relationships or alternative distribution models rather than traditional pharmacy benefit manager or group purchasing organization arrangements. The Texas Health and Human Services Commission represents the issuing-body type most active in this space — state health agencies managing pharmacy benefits for employee plans, Medicaid populations, or specialized treatment programs.

The single recent opportunity in the record is a Request for Information issued by the Texas Health and Human Services Commission in early April 2026 (RFI No. HHS0017013, posted April 3, 2026, response deadline April 3, 2026) soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. This RFI sought market intelligence on vendors' experience with direct contracting for self-insured employers and health plans, ability to negotiate net pricing models without rebates, and capacity to implement value-based or outcomes-based pharmaceutical agreements. The RFI functioned as a preliminary information-gathering mechanism to inform the state's future formal procurement strategy rather than a binding competitive solicitation with award values or budget specified. Geographic activity is limited to Texas in the recent record, and no other state or local jurisdictions appear in the current opportunity set for this code.